Cargando…
Consider Myocarditis When Patients Treated with Immune Checkpoint Inhibitors Present with Ocular Symptoms
Immune checkpoint inhibitors (ICIs) have been associated with neurological immune related adverse events (irAE-N) and patients with ICI toxicity may present with neurological or ocular symptoms. Furthermore, patients on ICI may initially present to oncology or neurology. We report a case series of 3...
Autores principales: | Rhee, John Y, Torun, Nurhan, Neilan, Tomas G, Guidon, Amanda C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074998/ https://www.ncbi.nlm.nih.gov/pubmed/35348772 http://dx.doi.org/10.1093/oncolo/oyac033 |
Ejemplares similares
-
Electrocardiographic features of immune checkpoint inhibitor associated myocarditis
por: Zlotoff, Daniel A, et al.
Publicado: (2021) -
Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action
por: Neilan, Tomas G., et al.
Publicado: (2018) -
Immune checkpoint inhibitor-related myocarditis: an illustrative case series of applying the updated Cardiovascular Magnetic Resonance Lake Louise Criteria
por: Wintersperger, Bernd J, et al.
Publicado: (2022) -
When should mechanical circulatory support be considered in pediatric patients with acute fulminant myocarditis?
por: Kwon, Hye Won
Publicado: (2020) -
Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors
por: Drobni, Zsofia D, et al.
Publicado: (2021)